Bristol-Myers Squibb Co. (BMY)


Common-Size Balance Sheet: Assets
Quarterly Data

Low level of difficulty

Bristol-Myers Squibb Co., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel LibreOffice Calc
Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Cash and cash equivalents 53.09 51.49 21.06 19.75 16.03 15.32 16.15 16.16 13.67 10.39 11.87 12.57 10.18 8.94 8.29 7.51 12.51 13.14 18.74 16.51 14.50 12.78 15.63
Marketable securities 3.57 1.73 4.10 5.64 4.22 3.30 4.32 4.15 7.29 9.08 6.68 6.27 6.31 5.23 5.21 5.94 4.53 4.00 3.91 5.52 7.09 8.64 5.49
Receivables 9.59 10.27 16.37 17.05 17.40 17.03 17.18 18.78 17.43 17.31 16.68 16.44 16.60 17.12 15.54 13.54 12.30 11.49 10.30 10.04 9.93 9.89 9.92
Inventories 2.08 2.37 3.68 3.42 3.80 3.81 3.72 3.48 3.68 3.64 4.20 3.68 4.39 4.38 4.19 3.85 3.56 4.08 4.28 4.62 4.68 4.97 4.95
Deferred income taxes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.45 5.92 5.61 4.87 4.51 4.05 4.16
Prepaid expenses and other 1.65 2.51 3.85 3.19 2.63 3.06 2.92 1.72 2.22 2.45 1.91 1.69 1.68 1.79 1.93 1.97 2.34 2.23 1.60 1.72 1.67 1.64 1.78
Current assets 69.98% 68.37% 49.07% 49.05% 44.08% 42.50% 44.28% 44.27% 44.29% 42.87% 41.34% 40.66% 39.15% 37.46% 35.17% 32.81% 40.67% 40.86% 44.45% 43.28% 42.38% 41.97% 41.93%
Property, plant and equipment 8.41 8.79 14.31 14.37 15.09 15.56 15.29 14.91 14.76 14.80 15.24 14.77 14.20 14.00 13.97 13.90 13.37 13.65 12.87 13.09 13.12 13.25 13.42
Goodwill 11.34 11.84 18.76 18.69 19.82 20.47 20.74 20.46 20.20 20.54 20.87 20.40 20.38 20.94 21.56 21.67 21.88 21.83 20.93 20.82 21.06 21.03 21.08
Other intangible assets 1.74 1.80 2.95 3.12 3.28 3.34 3.37 3.61 3.57 3.73 3.87 4.11 4.08 4.20 4.33 4.47 4.86 4.89 5.08 5.19 5.14 5.50 6.61
Deferred income taxes 2.83 2.61 3.96 3.92 4.82 4.65 4.13 4.80 6.90 7.70 7.95 8.89 10.46 10.32 10.13 8.96 2.26 1.81 2.04 2.71 3.03 2.61 2.36
Marketable securities 1.61 1.80 3.54 5.07 5.98 6.49 6.81 7.39 7.43 7.72 8.15 8.07 9.00 9.99 11.57 14.68 14.56 14.50 12.74 13.06 12.94 11.57 10.65
Other assets 4.09 4.77 7.41 5.79 6.92 6.99 5.37 4.57 2.84 2.64 2.57 3.11 2.72 3.08 3.29 3.52 2.40 2.46 1.89 1.84 2.33 4.07 3.96
Non-current assets 30.02% 31.63% 50.93% 50.95% 55.92% 57.50% 55.72% 55.73% 55.71% 57.13% 58.66% 59.34% 60.85% 62.54% 64.83% 67.19% 59.33% 59.14% 55.55% 56.72% 57.62% 58.03% 58.07%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (filing date: 2019-10-31), 10-Q (filing date: 2019-07-25), 10-Q (filing date: 2019-04-25), 10-K (filing date: 2019-02-25), 10-Q (filing date: 2018-10-25), 10-Q (filing date: 2018-07-26), 10-Q (filing date: 2018-04-26), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-26), 10-Q (filing date: 2017-07-27), 10-Q (filing date: 2017-04-27), 10-K (filing date: 2017-02-21), 10-Q (filing date: 2016-10-27), 10-Q (filing date: 2016-07-28), 10-Q (filing date: 2016-04-28), 10-K (filing date: 2016-02-12), 10-Q (filing date: 2015-10-27), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-28), 10-K (filing date: 2015-02-13), 10-Q (filing date: 2014-10-24), 10-Q (filing date: 2014-07-24), 10-Q (filing date: 2014-04-29).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Bristol-Myers Squibb Co.’s current assets as a percentage of total assets increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Bristol-Myers Squibb Co.’s property, plant and equipment as a percentage of total assets declined from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Bristol-Myers Squibb Co.’s non-current assets as a percentage of total assets declined from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.